Limba
|
Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of epidermal growth factor receptor (EGFR)and HER2mutations. Mobocertinib (TAK788) is an antineoplastic agent.
| Price | 992,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of epidermal growth factor receptor (EGFR)and HER2mutations. Mobocertinib (TAK788) is an antineoplastic agent. |